AU710105B2 - (-)-(3R0-3-methyl-4-(4-(4-(4-pyridyl)piperazin-1-yl)phenoxy) butyric acid as cellular adhesion inhibitor - Google Patents
(-)-(3R0-3-methyl-4-(4-(4-(4-pyridyl)piperazin-1-yl)phenoxy) butyric acid as cellular adhesion inhibitor Download PDFInfo
- Publication number
- AU710105B2 AU710105B2 AU58272/96A AU5827296A AU710105B2 AU 710105 B2 AU710105 B2 AU 710105B2 AU 58272/96 A AU58272/96 A AU 58272/96A AU 5827296 A AU5827296 A AU 5827296A AU 710105 B2 AU710105 B2 AU 710105B2
- Authority
- AU
- Australia
- Prior art keywords
- pharmaceutically
- optically active
- active compound
- ester
- amide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/457,538 US5652242A (en) | 1993-03-29 | 1995-06-01 | Heterocyclic derivatives |
US08/457538 | 1995-06-01 | ||
GBGB9518188.9A GB9518188D0 (en) | 1995-09-07 | 1995-09-07 | Optically active derivative |
GB9518188 | 1995-09-07 | ||
PCT/GB1996/001260 WO1996038416A1 (en) | 1995-06-01 | 1996-05-28 | (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazin-1-yl]phenoxy} butyric acid as cellular adhesion inhibitor |
Publications (2)
Publication Number | Publication Date |
---|---|
AU5827296A AU5827296A (en) | 1996-12-18 |
AU710105B2 true AU710105B2 (en) | 1999-09-16 |
Family
ID=26307696
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU58272/96A Ceased AU710105B2 (en) | 1995-06-01 | 1996-05-28 | (-)-(3R0-3-methyl-4-(4-(4-(4-pyridyl)piperazin-1-yl)phenoxy) butyric acid as cellular adhesion inhibitor |
Country Status (31)
Country | Link |
---|---|
EP (1) | EP0796247A1 (hu) |
JP (1) | JP2885941B2 (hu) |
KR (1) | KR100245957B1 (hu) |
AT (1) | AT406675B (hu) |
AU (1) | AU710105B2 (hu) |
BE (1) | BE1009520A5 (hu) |
BR (1) | BR9606409A (hu) |
CA (1) | CA2194397A1 (hu) |
CH (1) | CH691808A5 (hu) |
CZ (1) | CZ26997A3 (hu) |
DE (1) | DE19680509T1 (hu) |
DK (1) | DK10697A (hu) |
ES (1) | ES2137886B1 (hu) |
FI (1) | FI970393A (hu) |
GB (1) | GB2304340B (hu) |
GR (1) | GR1002702B (hu) |
HU (1) | HUP9700274A3 (hu) |
IE (1) | IE960405A1 (hu) |
IL (1) | IL118477A0 (hu) |
IT (1) | IT1290839B1 (hu) |
LU (1) | LU90008B1 (hu) |
MC (1) | MC2418A1 (hu) |
MX (1) | MX9700379A (hu) |
NL (1) | NL1003243C2 (hu) |
NO (1) | NO307460B1 (hu) |
NZ (1) | NZ308597A (hu) |
PL (1) | PL318440A1 (hu) |
SE (1) | SE510812C2 (hu) |
SK (1) | SK13097A3 (hu) |
TR (1) | TR199700020T1 (hu) |
WO (1) | WO1996038416A1 (hu) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994022835A2 (en) * | 1993-03-29 | 1994-10-13 | Zeneca Limited | Heterocyclic compounds as platelet aggregation inhibitors |
WO1994022834A1 (en) * | 1993-03-29 | 1994-10-13 | Zeneca Limited | Heterocyclic derivatives as platelet aggregation inhibitors |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0100158A3 (en) * | 1982-07-28 | 1985-03-27 | The Upjohn Company | (3-pyridinyl)heteroalkarylalkanols, alkanoic acids and esters |
GB8609630D0 (en) * | 1986-04-19 | 1986-05-21 | Pfizer Ltd | Anti-arrhythmia agents |
-
1996
- 1996-05-28 GR GR960100176A patent/GR1002702B/el not_active IP Right Cessation
- 1996-05-28 EP EP96919906A patent/EP0796247A1/en not_active Withdrawn
- 1996-05-28 HU HU9700274A patent/HUP9700274A3/hu unknown
- 1996-05-28 BR BR9606409A patent/BR9606409A/pt not_active Application Discontinuation
- 1996-05-28 MX MX9700379A patent/MX9700379A/es unknown
- 1996-05-28 WO PCT/GB1996/001260 patent/WO1996038416A1/en not_active IP Right Cessation
- 1996-05-28 NZ NZ308597A patent/NZ308597A/en unknown
- 1996-05-28 CH CH00224/97A patent/CH691808A5/de not_active IP Right Cessation
- 1996-05-28 DE DE19680509T patent/DE19680509T1/de not_active Withdrawn
- 1996-05-28 ES ES009750006A patent/ES2137886B1/es not_active Expired - Fee Related
- 1996-05-28 PL PL96318440A patent/PL318440A1/xx unknown
- 1996-05-28 GB GB9627127A patent/GB2304340B/en not_active Expired - Fee Related
- 1996-05-28 CZ CZ97269A patent/CZ26997A3/cs unknown
- 1996-05-28 JP JP8536281A patent/JP2885941B2/ja not_active Expired - Fee Related
- 1996-05-28 TR TR97/00020T patent/TR199700020T1/xx unknown
- 1996-05-28 AU AU58272/96A patent/AU710105B2/en not_active Ceased
- 1996-05-28 KR KR1019970700532A patent/KR100245957B1/ko not_active IP Right Cessation
- 1996-05-28 AT AT0900596A patent/AT406675B/de active
- 1996-05-28 SK SK130-97A patent/SK13097A3/sk unknown
- 1996-05-28 CA CA002194397A patent/CA2194397A1/en not_active Abandoned
- 1996-05-29 MC MC2347A patent/MC2418A1/xx unknown
- 1996-05-30 IL IL11847796A patent/IL118477A0/xx unknown
- 1996-05-31 NL NL1003243A patent/NL1003243C2/xx not_active IP Right Cessation
- 1996-05-31 IT IT96MI001113A patent/IT1290839B1/it active IP Right Grant
- 1996-05-31 IE IE960405A patent/IE960405A1/en not_active IP Right Cessation
- 1996-05-31 BE BE9600491A patent/BE1009520A5/fr not_active IP Right Cessation
-
1997
- 1997-01-22 LU LU90008A patent/LU90008B1/fr active
- 1997-01-24 SE SE9700203A patent/SE510812C2/sv not_active IP Right Cessation
- 1997-01-30 DK DK010697A patent/DK10697A/da not_active Application Discontinuation
- 1997-01-30 FI FI970393A patent/FI970393A/fi unknown
- 1997-01-31 NO NO970437A patent/NO307460B1/no not_active IP Right Cessation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994022835A2 (en) * | 1993-03-29 | 1994-10-13 | Zeneca Limited | Heterocyclic compounds as platelet aggregation inhibitors |
WO1994022834A1 (en) * | 1993-03-29 | 1994-10-13 | Zeneca Limited | Heterocyclic derivatives as platelet aggregation inhibitors |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69116285T2 (de) | Fibrinogen-Rezeptor-Antagonisten | |
US5561148A (en) | Adhesion receptor antagonists III | |
DE68915900T2 (de) | Angiogenese hemmendes Mittel. | |
JP2003514808A (ja) | 抗炎症剤としての尿素誘導体 | |
CZ297544B6 (cs) | Substituované N-[(aminoiminomethyl)-fenyl]propylamidy nebo N-[(aminomethyl)fenyl]propylamidy | |
CA2268621A1 (en) | 2-pipirazinone-1-acetic acid derivative, production and use thereof | |
AU758246B2 (en) | N,N-substituted cyclic amine derivatives | |
EP1124824B1 (de) | Chromenon- und chromanonderivate als integrinhemmer | |
KR100300566B1 (ko) | 피리미디논유도체와그의제조방법및용도 | |
EP1324992A1 (en) | Cyclized benzamide neurokinin antagonists for use in therapy | |
JPH021439A (ja) | ジアミン化合物、その製法及び該化合物を含有する高血圧症及び炎症を治療するための医薬 | |
US5134151A (en) | 2-picolylamine derivatives | |
DE69420345T2 (de) | Benzothiazolsulfonamid-derivate, verfahren zu deren herstellung und anwendungen | |
AU710105B2 (en) | (-)-(3R0-3-methyl-4-(4-(4-(4-pyridyl)piperazin-1-yl)phenoxy) butyric acid as cellular adhesion inhibitor | |
DE69813886T2 (de) | Naphthalin derivate | |
FR2758329A1 (fr) | Derives d'imidazole-4-butane boronique, leur preparation et leur utilisation en therapeutique | |
US4963587A (en) | Glycine derivative and pharmaceutical preparation thereof | |
JP2837318B2 (ja) | アンジオテンシンii拮抗性ピリジン誘導体 | |
JPH02243679A (ja) | 腫瘍転移阻害剤 | |
MXPA02006904A (es) | Fenilamidinas sustituidas, medicinas conteniendo estos compuestos y procedimientos para su preparacion. | |
RU2339634C2 (ru) | Кристаллическая форма | |
US5675011A (en) | Process for producing pyrrolidine derivative and salt thereof | |
FR2734818A1 (fr) | Acide (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazine-1-yl- phenoxy}-butyrique, procede pour sa preparation et composition pharmaceutique le contenant | |
SK283634B6 (sk) | Butadiénový, aminobutadiénový a pyrolidínový derivát a spôsoby ich prípravy | |
JPH06256331A (ja) | 血管新生阻害剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |